We noticed you’re blocking ads

Thanks for visiting CRSToday. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstoday.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Up Front | Jan 2015

Ch-Ch-Ch-Ch-Changes

I had a milestone birthday in November. After the shock of being 50 wore off, I thought about time and how my perception of it is always changing. When I was a kid, summer was a lengthy 3 months of “great.” Now, those same 3 months pass in a blink. I feel similarly when I look back at starting Bryn Mawr Communications (BMC) and launching Cataract & Refractive Surgery Today with business partner Adam Krafczek in 2001. We started with five employees and used office furniture in class C office space over the Mattress Giant store in Bryn Mawr, Pennsylvania. Those days are long gone. BMC now has more than 65 employees and offers publications and products in five medical specialties. Even so, BMC still has the feel of a new company, a startup in an environment of innovation.

An example of this balance can be seen in CRST. Now in its 15th year, CRST has undergone a makeover. The trend in print publications today is to shrink dimensions and lower the quality of the paper used. In typical BMC fashion, CRST’s dimensions have grown. We did not want to affect the publication’s portability, but we believe the slightly larger size will improve readers’ experiences by increasing the space for images—the iPhone 6 or 6+ (Apple) approach to publishing. We have also changed the publication’s name to the acronym CRST, because that is what most physicians and industry members call it. Although BMC is recognized as a progressive digital media company, the truth is that our print products have experienced significant and consistent growth year after year. In the field of medicine, print is alive and well!

In addition to its new look, CRST’s medical leadership has changed. After 5 years of deft guidance—the first 3 with fellow chief medical editor Stephen Slade, MD, and the last 2 with Steven Dell, MD—Eric Donnenfeld, MD, has passed the torch. Eric is one of the best-known physician leaders in cataract and refractive surgery. He has given so much to the field in the form of pharmaceutical and surgical research. He is also generous with his time and one of the most approachable key opinion leaders in ophthalmology, a gentle giant who makes me feel short at 6’ 2”. The past 5 years have passed quickly, and I feel fortunate to have become good friends with Eric. Even though he has stepped down from the chief medical editor position, I feel sure that Eric will continue to play a big role in the future of CRST and BMC.

Joining Steven as co-chief medical editor is Robert Weinstock, MD. Watch out, because Rob brings high energy and an innovative approach to everything he does. He is known as an innovator and an early adopter of cutting-edge technology, and he leads a very successful high-volume practice in Florida. I look forward to what the combination of Rob and Steven will bring, because I believe they are both tremendous “idea guys” who will usher CRST into a new era of educating surgeons.

I feel privileged to have worked closely with the talented and dedicated individuals in CRST’s chief medical editor position since 2001. There would be no CRST without the vision and efforts of John Doane, MD; David Chang, MD; Steve; Eric; and Steven. Their contributions led to the creation of Eyetube, CRST Europe, Glaucoma Today, Retina Today, Advanced Ocular Care, EyetubeOD, and MillennialEYE as well as to BMC’s expansion into the fields of cardiovascular diseases, dermatology, aesthetics, and neurology. These surgeons have left an indelible mark on this publication and BMC. I hope you enjoy the new CRST!n

David Cox
Publisher, CRST
Co-founder/President, BMC

Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below

NEXT IN THIS ISSUE